Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class ASSE: 688488

Announcement on Voluntary Disclosure of Marketing Authorization Approval Received for Dolutegravir Sodium Active Pharmaceutical Ingredient

· Issued by Jiangsu Aidea Pharmaceutical Group Co., Ltd. Class A via Shanghai Stock Exchange
Announcement on Voluntary Disclosure of Marketing Authorization Approval Received for Dolutegravir Sodium Active Pharmaceutical Ingredient

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment